Mhairi Maskew to Cost-Benefit Analysis
This is a "connection" page, showing publications Mhairi Maskew has written about Cost-Benefit Analysis.
Connection Strength
0,064
-
Initiating antiretroviral therapy for HIV at a patient's first clinic visit: a cost-effectiveness analysis of the rapid initiation of treatment randomized controlled trial. AIDS. 2017 Jul 17; 31(11):1611-1619.
Score: 0,032
-
Cohort profile: the Right to Care Clinical HIV Cohort, South Africa. BMJ Open. 2017 06 10; 7(6):e015620.
Score: 0,032